Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577447 · ClinicalTrials.gov registry record · NA
Docosahexaenoic Acid in the Treatment of Autism
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT00577447: Completed NA study, sponsored by Mayo Clinic.
NCT00577447 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577447, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that dietary supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) improves the behavior of children with autism.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT docosahexaenoic acid (DHA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00577447
The ClinicalTrials.gov registry entry for NCT00577447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00577447 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00577447 about?
NCT00577447 is a clinical study titled "Docosahexaenoic Acid in the Treatment of Autism". The purpose of this study is to test the hypothesis that dietary supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) improves the behavior of children with autism.
What is the current status of trial NCT00577447?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2005-10. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00577447?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), docosahexaenoic acid (DHA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00577447?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.